FDA Drafts Guidance on Replacing Reagents for IVD Devices Post author:Sam Post published:February 15, 2018 Post category:The GMP Letter The FDA issued draft guidance to provide updates on in vitro diagnostics’ replacement reagents. Source: The GMP Letter You Might Also Like Notified Bodies Warn of Future Bottlenecks in Implementing New Device Regs February 8, 2019 How Post-Brexit Changes Will Impact Devicemakers January 7, 2021 Canada Issues Guidance on Cybersecurity Requirements January 11, 2019